The valuation of the EQ-5D in Portugal

Quality of Life Research

Volumn 23, Issue 2, 2014, Pages 413-423

  Ferreira, Lara N ^a,c   Ferreira, Pedro L ^b,c   Pereira, Luis N ^a   Oppe, Mark ^d  

^a UNIVERSITY OF ALGARVE   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

EQ 5D; Health related quality of life; QALYs; TTO; Utility; Value set

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; INTERVIEW; MALE; METHODOLOGY; MIDDLE AGED; PORTUGAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; STANDARD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; INTERVIEWS AS TOPIC; LEAST-SQUARES ANALYSIS; MALE; MIDDLE AGED; PORTUGAL; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; YOUNG ADULT;

EID: 84900150292     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-013-0448-z     Document Type: Article

References (34)

1. Brooks, R. (1996). EuroQol: The current state of play. Health Policy, 37, 53-72.
2. Dolan, P. (1997). Modelling valuations for EuroQol health states. Medical Care, 35, 1095-1108.
3. Brazier, J.; Roberts, J.; Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21, 271-292.
4. Brazier, J.; Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42(9), 851-859.
5. Torrance, G.; Boyle, M.; Horwood, S. (1982). Application of multi-attribute utility theory to measure social preferences for health states. Operations Research, 30(6), 1043-1069.
6. Torrance, G.; Feeny, D.; Furlong, W.; Barr, R.; Zhang, Y.; Wang, Q. (1996). Multi-attribute utility function for a comprehensive health status classification system: Health utilities index mark 2. Medical Care, 34(7), 702-722.
7. Feeny, D.; Furlong, W.; Torrance, G.; Goldsmith, C.; Zhu, Z.; DePauw, S.; et al. (2002). Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care, 40(2), 113-128.
8. Ferreira, L.; Ferreira, P. (2013). Health state values, methods, Portugal and the UK. In A. Michalos (Ed.), Encyclopedia of quality of life research. Springer (forthcoming).
9. Szende, A.; Oppe, M.; Charro, F. d. (2007). Comparative review of time trade-off value sets. In A. Szende, M. Oppe, & N. Devlin (Eds.), EQ-5D value sets - inventory, comparative review and user guide (vol. 2, pp. 21-28): EuroQol Group Monographs.
10. Cleemput, I. (2010). A social preference valuations set for EQ-5D health states in Flanders, Belgium. The European Journal Health Economics, 11, 205-213.
11. Wittrup-Jensen, K.; Lauridsen, J.; Gudex, C.; Pedersen, K. (2009). Generation of a Danish TTO value set for EQ-5D health states. Scandinavian Journal of Public Health, 37(5), 459-466. doi: 10.1177/1403494809105287.
12. Greiner, W.; Claes, C.; Busschbach, J.; Schulenburg, J.-M. (2005). Validating the EQ-5D with time trade-off for the German population. The European Journal of Health Economics, 6, 124-130.
13. Ohinmaa, A.; Eija, H.; Sintonen, H. Modelling Euro-Qol values of Finnish adult population. In X. Badia, M. Herdman, & A. Segura (Eds.), EuroQol 1995 Barcelona plenary meeting, Barcelona, 3-6 October 1996 (pp. 67-76): Institut de Salut Pública de Catalunya.
14. Chevalier, J.; Pouvourville, G. (2012). Valuing EQ-5D using time trade-off in France. The European Journal Health Economics, doi: 10.1007/s10198-011-0351-x.
15. Lamers, L.; McDonnell, J.; Stalmeier, P.; Krabbe, P.; Busschbach, J. (2006). The Dutch tariff: Results and arguments for an effective design for national EQ-5D valuation studies. Health Economics, 15(10), 1121-1132.
16. Golicki, D.; Jakubczyk, M.; Niewada, M.; Wrona, W.; Busschbach, J. (2010). Valuation of EQ-5D health states in Poland: First TTO-based social value set in Central and Eastern Europe. Value in Health, 13(2), 289-297.
17. Rupel, V.; Ogorevc, M. (2012). The EQ-5D health states value set for Slovenia. Slovenian Journal of Public Health, 51(2), 128-140.
18. Badia, X.; Roset, M.; Herdman, M.; Kind, P. (2001). A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Medical Decision Making, 21(1), 7-16.
19. Augustovski, F. A.; Irazola, V. E.; Velasquez, A. P.; Gibbons, L.; Craig, B. M. (2009). Argentin valuation of the EQ-5D health states. Value in Health, 12(4), 587-596.
20. Viney, R.; Norman, R.; King, M. T.; Cronin, P.; Street, D. J.; Knox, S.; et al. (2011). Time trade-off derived EQ-5D weights for Australia. Value in Health, 14(6), 928-936.
21. Bansback, N.; Tsuchiya, A.; Brazier, J.; Anis, A. (2012). Canadian valuation of EQ-5D health states: Preliminary value set and considerations for future valuation studies. PLoS ONE, 7(2), e31115. doi: 10.1371/journal.pone. 0031115.
22. Tsuchiya, A.; Ikeda, S.; Ikegami, N.; Nishimura, S.; Sakai, I.; Fukuda, T.; et al. (2002). Estimating an EQ-5D population value set: The case of Japan. Health Economics, 11(4), 341-353.
23. Devlin, N.; Hansen, P.; Kind, P.; Williams, A. (2003). Logical inconsistencies in survey respondents' health state valuations - a methodological challenge for estimating social tariffs. Health Economics, 12(7), 529-544.
24. Tongsiri, S.; Cairns, J. (2011). Estimating population-based values for EQ-5D health states in Thailand. Value in Health, 14(8), 1142-1145.
25. Shaw, J.; Johnson, J.; Coons, S. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 model. Medical Care, 43, 203-220.
26. Jelsma, J.; Hansen, K.; Weerdt, W.; Cock, P.; Kind, P. (2003). How do Zimbabweans value health states? Population Health Metrics, 7, 11.
27. Greiner, W.; Weijnen, T.; Nieuwenhuizen, M.; Oppe, S.; Badia, X.; Busschbach, J.; et al. (2003). A single European currency for EQ-5D health states: Results from a six-country study. The European Journal of Health Economics, 4, 222-231.
28. Silva, E.; Gouveia Pinto, C.; Sampaio, C.; Pereira, J.; Drummond, M.; Trindade, R. (1998). Guidelines for economic drug evaluation studies. Lisbon: INFARMED.
29. Portuguese Statistical Office (2012). Census 2011.
30. Kind, P.; Dolan, P.; Gudex, C.; Williams, A. (1998). Variations in population health status: Results from a United Kingdom national questionnaire survey. British Medical Journal, 16, 736-741.
31. Agency for Healthcare Research and Quality (2005). EQ-5D Health State Valuation Survey Conducted by Research Triangle Institute on Behalf of the University of Arizona Center for Health Outcomes and PharmacoEconomic Research-Interviewer Book. http://www.ahrq.gov/professionals/clinicians- providers/resources/rice/EQ-5D/forms/EQ5Dbook.pdf. Accessed 27 Dec 2011.
32. Mann, R.; Brazier, J.; Tsuchiya, A. (2009). A comparison of patient and general population weightings of EQ-5D dimensions. Health Economics, 18, 363-372.
33. Zarate, V.; Kind, P.; Chuang, L.-H. (2008). Hispanic valuation of the EQ-5D health states: A social value set for Latin Americans. Value in Health, 11(7), 1170-1177.
34. Bernert, S.; Fernández, A.; Haro, J.; König, H-. H.; Alonso, J.; Vilagut, G.; et al. (2009). Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries. Value in Health, 12(5), 750-758.